Related references
Note: Only part of the references are listed.Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma
N Yajima et al.
CLINICAL CANCER RESEARCH (2005)
Exosomes as potent cell-free peptide-based vaccine.: I.: Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells
F André et al.
JOURNAL OF IMMUNOLOGY (2004)
Detection of human polyomaviruses in urine from bone marrow transplant patients:: Comparison of electron microscopy with PCR
SS Biel et al.
CLINICAL CHEMISTRY (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
R Yamanaka et al.
BRITISH JOURNAL OF CANCER (2003)
Production and characterization of clinical grade exosomes derived from dendritic cells
HG Lamparski et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Malignant effusions and immunogenic tumour-derived exosomes
F Andre et al.
LANCET (2002)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes
D Skokos et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
